• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清肌酐/胱抑素C比值是80岁以上老年人全因死亡率的一个预测指标。

Serum creatinine/cystatin C ratio is a predictor of all-cause mortality for older adults over 80 years.

作者信息

Zhang Li, Jin Jun, Tu You-Yi, Zhao Zhe, Tao Jun, Zhang Xiao-Yan

机构信息

Department of Geriatrics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 600, Yi Shan Road, Shanghai, 200233, China.

出版信息

Heliyon. 2023 Mar 8;9(3):e14214. doi: 10.1016/j.heliyon.2023.e14214. eCollection 2023 Mar.

DOI:10.1016/j.heliyon.2023.e14214
PMID:36994407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10040501/
Abstract

OBJECTIVE

Sarcopenia is a prevalent condition in the senior population and has been related to adverse outcomes. This study aimed to investigate the performance of the serum creatinine/cystatin C ratio (Cr/CysC) in predicting all-cause mortality in elders over 80 years.

METHODS

A total of 486 older patients over 80 were enrolled in this study. Calf circumference (CC) and handgrip strength (HGS) were carried out for each patient. All the participants accepted serum creatinine and cystatin C test. The primary clinical outcome was all-cause mortality during an over-4-year follow-up.

RESULTS

During an over 4-year follow-up, 200 participants died. The non-survivors had a significantly lower baseline Cr/CysC level than the survivors (62.6 ± 13.1 vs. 71.4 ± 14.5  < 0.001). The lowest Cr/CysC quartile group (Q1) had a significantly higher mortality rate than their counterparts (Q1 vs. Q2-4, 62.8% vs. 33.2%,  < 0.001). The Cr/CysC level was positively correlated with CC (R = 0.17,  < 0.001) and HGS (R = 0.19,  < 0.001). Moreover, survival curve was significantly worse in the lowest Cr/CysC quartile (Log-rank test χ = 21.09,  < 0.001). After adjustment for potential confounders, age (HR, 1.10; 95% CI, 1.06-1.14,  < 0.001), coronary heart disease (HR, 1.49; 95% CI, 1.01-2.21,  = 0.045), and lowest Cr/CysC (HR, 1.59; 95% CI, 1.12-2.24,  = 0.009) were independent factors of all-cause mortality during the over-4-year follow-up.

CONCLUSION

Cr/CysC, also known as Sarcopenia Index, could be used as a predictor of all-cause mortality in older adults over 80 years.

摘要

目的

肌肉减少症在老年人群中普遍存在,且与不良后果相关。本研究旨在调查血清肌酐/胱抑素C比值(Cr/CysC)在预测80岁以上老年人全因死亡率方面的表现。

方法

本研究共纳入486名80岁以上的老年患者。对每位患者进行小腿围(CC)和握力(HGS)测量。所有参与者均接受血清肌酐和胱抑素C检测。主要临床结局为4年以上随访期间的全因死亡率。

结果

在4年以上的随访期间,200名参与者死亡。非幸存者的基线Cr/CysC水平显著低于幸存者(62.6±13.1 vs. 71.4±14.5,<0.001)。最低Cr/CysC四分位数组(Q1)的死亡率显著高于其他组(Q1 vs. Q2 - 4,62.8% vs. 33.2%,<0.001)。Cr/CysC水平与CC呈正相关(R = 0.17,<0.001),与HGS呈正相关(R = 0.19,<0.001)。此外,最低Cr/CysC四分位数组的生存曲线明显更差(对数秩检验χ = 21.09,<0.001)。在对潜在混杂因素进行调整后,年龄(HR,1.10;95%CI,1.06 - 1.14,<0.001)、冠心病(HR,1.49;95%CI,1.01 - 2.21,= 0.045)和最低Cr/CysC(HR,1.59;95%CI,1.12 - 2.24,= 0.009)是4年以上随访期间全因死亡率的独立因素。

结论

Cr/CysC,也称为肌肉减少症指数,可作为80岁以上老年人全因死亡率的预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/10040501/731bd395bed1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/10040501/b3c256398529/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/10040501/731bd395bed1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/10040501/b3c256398529/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/10040501/731bd395bed1/gr2.jpg

相似文献

1
Serum creatinine/cystatin C ratio is a predictor of all-cause mortality for older adults over 80 years.血清肌酐/胱抑素C比值是80岁以上老年人全因死亡率的一个预测指标。
Heliyon. 2023 Mar 8;9(3):e14214. doi: 10.1016/j.heliyon.2023.e14214. eCollection 2023 Mar.
2
Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.血清肌酐/胱抑素C比值是胃肠道间质瘤患者肌肉减少症的一个全身性标志物。
Front Nutr. 2022 Sep 2;9:963265. doi: 10.3389/fnut.2022.963265. eCollection 2022.
3
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.血清肌酐/胱抑素 C 比值作为慢性阻塞性肺疾病患者肌少症的替代标志物。
Clin Nutr. 2021 Mar;40(3):1274-1280. doi: 10.1016/j.clnu.2020.08.010. Epub 2020 Aug 19.
4
Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.血清肌酐/胱抑素 C 比值是特发性肺纤维化患者肌少症的替代标志物。
BMC Pulm Med. 2022 May 23;22(1):203. doi: 10.1186/s12890-022-02000-3.
5
The diagnostic performance of Cr/CysC for sarcopenia and its predictive value on clinical outcomes in hospitalized older patients: a prospective cohort study.肌少症诊断性能的 Cr/CysC 及其对住院老年患者临床结局的预测价值:一项前瞻性队列研究。
Eur Geriatr Med. 2024 Apr;15(2):579-588. doi: 10.1007/s41999-024-00948-5. Epub 2024 Feb 23.
6
The relationship between serum creatinine/cystatin C ratio and mortality in hypertensive patients.高血压患者血清肌酐/胱抑素C比值与死亡率的关系。
Nutr Metab Cardiovasc Dis. 2024 Feb;34(2):369-376. doi: 10.1016/j.numecd.2023.09.004. Epub 2023 Sep 12.
7
Clinical muscle mass-related biomarkers that predict mortality in older patients with community-acquired pneumonia.与肌肉量相关的临床生物标志物可预测社区获得性肺炎老年患者的死亡率。
BMC Geriatr. 2022 Nov 19;22(1):880. doi: 10.1186/s12877-022-03626-y.
8
Prognostic value of the serum creatinine/cystatin C ratio in patients with chronic obstructive pulmonary disease.血清肌酐/胱抑素 C 比值在慢性阻塞性肺疾病患者中的预后价值。
Respir Investig. 2024 Jan;62(1):143-149. doi: 10.1016/j.resinv.2023.11.007. Epub 2023 Dec 21.
9
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.血清肌酐/胱抑素 C 比值作为胃癌患者肌少症的替代标志物。
BMC Gastroenterol. 2022 Jan 19;22(1):26. doi: 10.1186/s12876-022-02093-4.
10
Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer.血清肌酐和胱抑素 C 比值对胆道癌患者肌肉减少症及预后预测的影响。
Int J Clin Oncol. 2024 Jul;29(7):1002-1011. doi: 10.1007/s10147-024-02539-7. Epub 2024 Apr 29.

引用本文的文献

1
The Predictive Power of the Cystatin C-Creatinine Score in Assessing Frailty.胱抑素C-肌酐评分在评估衰弱方面的预测能力。
J Cachexia Sarcopenia Muscle. 2025;16(4):e70040. doi: 10.1002/jcsm.70040.
2
Association between sarcopenia index and the risk of second hip fracture in older adults.老年人体成分减少指数与二次髋部骨折风险之间的关联。
J Nutr Health Aging. 2025 Jun;29(6):100532. doi: 10.1016/j.jnha.2025.100532. Epub 2025 Mar 12.
3
Cystatin C and sarcopenia index are associated with cardiovascular and all-cause death among adults in the United States.

本文引用的文献

1
Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS.老年人肌少症与轻度认知障碍:来自 CHARLS 的首个纵向证据。
J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2944-2952. doi: 10.1002/jcsm.13081. Epub 2022 Sep 4.
2
Relationship of creatinine cystatin C ratio with muscle mass and grip strength in memory clinic outpatients.记忆门诊患者中肌酐与胱抑素C比值与肌肉质量和握力的关系。
Exp Gerontol. 2022 Oct 15;168:111935. doi: 10.1016/j.exger.2022.111935. Epub 2022 Aug 28.
3
Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review.
胱抑素 C 和肌肉减少症指数与美国成年人的心血管疾病和全因死亡相关。
BMC Public Health. 2024 Jul 23;24(1):1972. doi: 10.1186/s12889-024-19137-x.
4
Associations of serum albumin and dietary protein intake with all-cause mortality in community-dwelling older adults at risk of sarcopenia.血清白蛋白和膳食蛋白质摄入量与有肌肉减少症风险的社区居住老年人全因死亡率的关联。
Heliyon. 2024 Apr 16;10(8):e29734. doi: 10.1016/j.heliyon.2024.e29734. eCollection 2024 Apr 30.
根据 EWGSOP1 和 EWGSOP2 诊断老年人肌少症的流行率及其与不良健康结局的相关性:系统评价。
Aging Clin Exp Res. 2022 Mar;34(3):505-514. doi: 10.1007/s40520-021-01951-7. Epub 2021 Aug 16.
4
Association of Creatinine-to-Cystatin C Ratio with Myosteatosis and Physical Performance in Older Adults: The Japan Shimanami Health Promoting Program.老年人体内肌酐与胱抑素C比值与肌少症及身体机能的关联:日本下滩健康促进项目
J Am Med Dir Assoc. 2021 Nov;22(11):2366-2372.e3. doi: 10.1016/j.jamda.2021.03.021. Epub 2021 Apr 27.
5
Sarcopenia Index as a Predictor of Clinical Outcomes in Older Patients with Coronary Artery Disease.肌肉减少症指数作为老年冠心病患者临床结局的预测指标
J Clin Med. 2020 Sep 27;9(10):3121. doi: 10.3390/jcm9103121.
6
Comparison of the value of malnutrition and sarcopenia for predicting mortality in hospitalized old adults over 80 years.比较营养不良和肌肉减少症对 80 岁以上住院老年人死亡率的预测价值。
Exp Gerontol. 2020 Sep;138:111007. doi: 10.1016/j.exger.2020.111007. Epub 2020 Jun 23.
7
Cystatin C as a biomarker of chronic kidney disease: latest developments.胱抑素 C 作为慢性肾脏病的生物标志物:最新进展。
Expert Rev Mol Diagn. 2020 Oct;20(10):1019-1026. doi: 10.1080/14737159.2020.1768849. Epub 2020 May 25.
8
Predictive Value of Nutritional Risk Screening 2002 and Mini Nutritional Assessment Short Form in Mortality in Chinese Hospitalized Geriatric Patients.营养风险筛查 2002 及微型营养评估简表对中国住院老年患者死亡率的预测价值。
Clin Interv Aging. 2020 Mar 20;15:441-449. doi: 10.2147/CIA.S244910. eCollection 2020.
9
Reference Values for Skeletal Muscle Mass - Current Concepts and Methodological Considerations.骨骼肌质量的参考值 - 当前概念和方法学考虑。
Nutrients. 2020 Mar 12;12(3):755. doi: 10.3390/nu12030755.
10
Malnutrition as a Strong Predictor of the Onset of Sarcopenia.营养不良是肌少症发生的强烈预测因子。
Nutrients. 2019 Nov 27;11(12):2883. doi: 10.3390/nu11122883.